Comparative Incidence of Patellofemoral Complications Between 2 Total Knee Arthroplasty Systems in a Multicenter, Prospective Clinical Study.

Autor: Toomey SD; Orthopedic Physician Associates, Seattle, Washington., Daccach JA; DePuy Synthes, Warsaw, Indiana., Shah JC; DePuy Synthes, Warsaw, Indiana., Himden SE; DePuy Synthes, Warsaw, Indiana., Lesko JP; DePuy Synthes, Warsaw, Indiana., Hamilton WG; Anderson Orthopaedic Research Institute, Alexandria, Virginia.
Jazyk: angličtina
Zdroj: The Journal of arthroplasty [J Arthroplasty] 2017 Sep; Vol. 32 (9S), pp. S187-S192. Date of Electronic Publication: 2017 Apr 20.
DOI: 10.1016/j.arth.2017.04.014
Abstrakt: Background: Cumulative incidence rates (CIRs) of patellofemoral complications (PCCs) and patellofemoral symptomatic crepitus (SC) using a new knee system-total knee arthroplasty (NEW-TKA) were compared with those of a currently available product-total knee arthroplasty (CA-TKA).
Methods: Twenty-two investigators prospectively enrolled 704 patients into a study using CA-TKA; 364 received a posterior-stabilized configuration. Twenty-three investigators (19 from the CA-TKA study) enrolled 1138 patients with NEW-TKA; 584 received a posterior-stabilized configuration. CIRs were estimated with Kaplan-Meier methods.
Results: CA-TKA had 32 PCCs (6.15% CIR at 1 year and 8.26% at 2 years). NEW-TKA had 19 PCCs (3.15% CIR at 1 year and 4.11% at 2 years). CA-TKA had 15 SCs, 12 before 2 years (CIR = 3.67%); NEW-TKA had 5 SCs before 2 years (CIR = 1.21%). NEW-TKA had a statistically lower CIR of overall PCC and SC (log-rank P values = .018 for PCC and .017 for SC).
Conclusion: Interim 1- and 2-year CIRs of PCC and SC in NEW-TKA were less than half of those for CA-TKA, which is a promising trend for this new implant.
(Copyright © 2017 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: